Clinical trial
Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia
NCT00654706
Study timeline
Study start (unknown)2008-03-01Date precision: month
Registry last updated2014-05-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Cognitionunresolved
Interventions
SertindoleDRUG
QuetiapineDRUG · verified · RxNorm: quetiapine
Sponsors & collaborators
H. Lundbeck A/Slead sponsor
Mapped research locations
HoustonTexas, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1San DiegoCalifornia, United States1TampaFlorida, United States1DurhamNorth Carolina, United States1AuroraColorado, United States1AustinTexas, United States1CharlotteNorth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00654706 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.